K279-0828 Screening compound: N~1~-CYCLOHEXYL-2-[(3-{3-[(2-METHOXYBENZYL)AMINO]-3-OXOPROPYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]BUTANAMIDE

K279-0828 Screening compound: N~1~-CYCLOHEXYL-2-[(3-{3-[(2-METHOXYBENZYL)AMINO]-3-OXOPROPYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]BUTANAMIDE
K279-0828 Screening compound: N~1~-CYCLOHEXYL-2-[(3-{3-[(2-METHOXYBENZYL)AMINO]-3-OXOPROPYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]BUTANAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-0828
N~1~-CYCLOHEXYL-2-[(3-{3-[(2-METHOXYBENZYL)AMINO]-3-OXOPROPYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]BUTANAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-0828

Molecular Formula

C31H37N5O4S (C31 H37 N5 O4 S)

Compound Name

N~1~-CYCLOHEXYL-2-[(3-{3-[(2-METHOXYBENZYL)AMINO]-3-OXOPROPYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]BUTANAMIDE

IUPAC name

n/a

SMILES

CCC(C(NC1CCCCC1)=O)SC(N1C2CCC(NCc(cccc3)c3OC)=O)=Nc(cccc3)c3C1=NC2=O

InChI

InChI=1S/C31H37N5O4S/c1-3-26(30(39)33-21-12-5-4-6-13-21)41-31-34-23-15-9-8-14-22(23)28-35-29(38)24(36(28)31)17-18-27(37)32-19-20-11-7-10-16-25(20)40-2/h7-11,14-16,21,24,26H,3-6,12-13,17-19H2,1-2H3,(H,32,37)(H,33,39)

InChI Key

VRWIOTXVOZNMFM-UHFFFAOYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

575.73

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.388

Distribution Coefficient, logD

4.387

Water Solubility, LogSw

-4.38

Polar Surface Area

91.664

Acid Dissociation Constant (pKa)

10.29

Base Dissociation Constant (pKb)

4.20

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

45.20

K279-0828 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with K279-0828 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-0828?
Check Price and Availability of K279-0828, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-0828 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-0828
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-0828
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-0828 available by request